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Abstract
The health benefits of green tea for a wide variety of ailments, including different types of cancer, heart disease,
and liver disease, were reported. Many of these beneficial effects of green tea are related to its catechin, particu-
larly (-)-epigallocatechin-3-gallate, content. There is evidence from in vitro and animal studies on the underlying
mechanisms of green tea catechins and their biological actions. There are also human studies on using green tea
catechins to treat metabolic syndrome, such as obesity, type II diabetes, and cardiovascular risk factors.
Long-term consumption of tea catechins could be beneficial against high-fat diet-induced obesity and type II dia-
betes and could reduce the risk of coronary disease. Further research that conforms to international standards
should be performed to monitor the pharmacological and clinical effects of green tea and to elucidate its mechan-
isms of action.
Background
In recent years, the health benefits [1] of consuming
green tea, including the prevention of cancer [2] and
cardiovascular diseases [3], the anti-inflammatory [4],
antiarthritic [5], antibacterial [6], antiangiogenic [7],
antioxidative [8], antiviral [9], neuroprotective [10], and
cholesterol-lowering effects [11] of green tea and iso-
lated green tea constituents are under investigation.
However, adding green tea to the diet may cause other
serious health concerns.
The health-promoting effects of green tea are mainly
attributed to its polyphenol content [12], particularly fla-
vanols and flavonols, which represent 30% of fresh leaf
dry weight [1]. Recently, many of the aforementioned
beneficial effects of green tea were attributed to its most
abundant catechin, (-)-epigallocatechin-3-gallate (EGCG)
[13-15]. Green tea extracts are more stable than pure
epigallocatechin gallate, one of the major constituents of
green tea, because of the presence of other antioxidant
constituents in the extract [8]. In general, herbal medi-
cines are complex mixtures of different compounds that
often act in a synergistic fashion to exert their full bene-
ficial effect [11]. However, relatively few herbal medi-
cines have been well characterized and their efficacy
demonstrated in systematic clinical trials as compared
to Western drugs. This review article highlights the
recent research on the efficacy, action mechanisms, and
side effects of green tea and its catechins in in vitro,
in vivo, and ex vivo systems [16].
The review on green tea and its catechins focused on
language literature in English. The literature search was
conducted in the following databases: Pubmed (1980-
2009), EMBASE (1980-2009), Allied and complementary
Medicine Database (AMED, 1985-2009) and China Jour-
nals Full Text Database (1975-2009). The keywords used
were selected from the following terms: green tea, cate-
chins, anticancer, diabetes, polyphenols, in vivo studies,
general pharmacology and toxicology. The health bene-
fits and adverse effects of green tea and its catechins
were reviewed.
The authors read full articles and reached consensus
after discussion. Articles included in the study covered
the following effects of green tea: (1) the health benefits
in humans and animals, (2) absorption of metal ions
and drug-metabolizing enzymes, (3) antioxidation and
inhibition of oxidative stress, (4) carbohydrate metabo-
lism and diabetes mellitus, and (5) adverse effects. A
total of 105 peer-reviewed papers in English were
selected for this review.
Green tea
Tea is one of the most popular beverages consumed
worldwide. Tea, from the plant Camellia sinensis,i s
consumed in different parts of the world as green, black,
or Oolong tea. Among all of these, however, the most
significant effects on human health have been observed
with the consumption of green tea [17]. The first green
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century. It is estimated that about 2.5 million tons of
tea leaves are produced each year throughout the world,
with 20% produced as green tea, which is mainly con-
sumed in Asia, some parts of North Africa, the United
States, and Europe [18]. The association between tea
consumption, especially green tea, and human health
has long been appreciated [19,20]. Green tea and black
tea are processed differently during manufacturing. To
produce green tea, freshly harvested leaves are immedi-
ately steamed to prevent fermentation, yielding a dry,
stable product. This steaming process destroys the
enzymes responsible for breaking down the color pig-
ments in the leaves and allows the tea to maintain its
green color during the subsequent rolling and drying
processes. These processes preserve natural polyphenols
with respect to the health-promoting properties. As
green tea is fermented to Oolong and then to black tea,
polyphenol compounds (catechins) in green tea are
dimerized to form a variety of theaflavins, such that
these teas may have different biological activities.
Green tea composition
The chemical composition of green tea is complex: pro-
teins (15-20% dry weight), whose enzymes constitute an
important fraction; amino acids (1-4% dry weight) such
as theanine or 5-N-ethylglutamine, glutamic acid, trypto-
phan, glycine, serine, aspartic acid, tyrosine, valine,
leucine, threonine, arginine, and lysine; carbohydrates
(5-7% dry weight) such as cellulose, pectins, glucose,
fructose, and sucrose; minerals and trace elements (5%
dry weight) such as calcium, magnesium, chromium,
manganese, iron, copper, zinc, molybdenum, selenium,
sodium, phosphorus, cobalt, strontium, nickel, potas-
sium, fluorine, and aluminum; and trace amounts of
lipids (linoleic and a-linolenic acids), sterols (stigmas-
terol), vitamins (B, C, E), xanthic bases (caffeine,
theophylline), pigments (chlorophyll, carotenoids), and
volatile compounds (aldehydes, alcohols, esters, lactones,
hydrocarbons). Due to the great importance of the
mineral presence in tea, many studies have determined
their levels in tea leaves and their infusions (Table 1)
[21]. Fresh leaves contain, on average, 3-4% of alkaloids
known as methylxanthines, such as caffeine, theobro-
mine, and theophylline [22]. In addition, there are
phenolic acids such as gallic acids and characteristic
amino acid such as theanine present [22].
Green tea contains polyphenols, which include flava-
nols, flavandiols, flavonoids, and phenolic acids; these
compounds may account for up to 30% of the dry
weight. Most of the green tea polyphenols (GTPs) are
flavonols, commonly known as catechins. Products
derived from green tea are mainly extracts of green tea
in liquid or powder form that vary in the proportion of
polyphenols (45-90%) and caffeine content (0.4-10%).
The major flavonoids of green tea are various catechins,
which are found in greater amounts in green tea than in
black or Oolong tea [23]. There are four kinds of cate-
chins mainly find in green tea: epicatechin, epigallocate-
chin, epicatechin-3-gallate, and EGCG [24]. The
preparation methods influence the catechins both quan-
titatively and qualitatively; the amount of catechins also
varies in the original tea leaves due to differences in
variety, origin, and growing conditions [25]. The pre-
paration of fresh green tea cannot totally extract cate-
chins from the leaves; therefore, the concentration
found differs from the absolute values determined
through the complete extraction of leaves [26]. More-
over, catechins are relatively unstable and could be
quantitatively and qualitatively modified during the time
frame of an experiment [27,28]. Thus, comparison of
ingested doses in animal studies is not possible because
the catechin quantification before administration is
often not known.
Health benefits of green tea in humans and animals
Studies using animal models show that green tea catechins
provide some protection against degenerative diseases
[29]. Some studies indicated that green tea has an antipro-
liferative activity on hepatoma cells and a hypolipidemic
activity in hepatoma-treated rats, as well as the prevention
of hepatoxicity [29] and as a preventive agent against
mammary cancer post-initiation [29]. Green tea catechins
could also act as antitumorigenic agents [30] and as
immune modulators in immunodysfunction caused by
transplanted tumors or by carcinogen treatment [29].
Moreover, green tea, its extract, and its isolated constitu-
ents were also found to be effective in preventing oxidative
stress [31] and neurological problems [32].
Green tea consumption has also been linked to the
prevention of many types of cancer, including lung,
Table 1 Composition (%) of green tea, black tea, and
black tea infusion [21]
Compound Green Tea* Black tea* Infusion*
Protein 15 15 trace
Amino acids 4 4 3.5
Fiber 26 26 0
Others carbohydrates 7 7 4
Lipids 7 7 trace
Pigments 2 2 trace
Minerals 5 5 4.5
Phenolic compounds
‡ 30 5 4.5
Oxidized phenolic compounds
§ 0 25 4.5
* Data refer to dry weight of tea leaves.
† Infusion time: 3 minutes
‡ Especially flavonoids
§ Especially thearubigins and theaflavins
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ney, pancreas, and mammary glands [33]. Several epide-
miological studies and clinical trials showed that green
tea (and black and Oolong teas to a lesser extent) may
reduce the risk of many chronic diseases [34]. This ben-
eficial effect has been attributed to the presence of high
amounts of polyphenols, which are potent antioxidants.
In particular, green tea may lower blood pressure and
thus reduce the risk of stroke and coronary heart dis-
ease. Some animal’s studies suggested that green tea
might protect against the development of coronary heart
d i s e a s eb yr e d u c i n gb l o o dg l u c o s el e v e l sa n db o d y
weight [35]. However, all these data are based on mid-
dle-aged animals’ populations, not the elderly popula-
tions, which nutritional status tends to be more
adversely influenced by age-related biological and socio-
economic factors [36].
Tea components possess antioxidant, antimutagenic,
and anticarcinogenic effects and could protect humans
against the risk of cancer by environmental agents [37].
Sano et al. [38] reported the inhibitory effects of green
tea leaves against tert-butyl hydroperoxide-induced lipid
peroxidation, and a similar antioxidant effect on the kid-
ney was observed after oral administration of the major
tea polyphenol EGCG. The antioxidative potency of
crude catechin powder and individual catechins was
tested in experiments using the active oxygen method.
Crude catechins reduced the formation of peroxides far
more effectively than dl-a-tocopherol [39]. Shim et al.
[40] studied the chemopreventive effect of green tea
among cigarette smokers and found that it can block
the cigarette-induced increase in sister chromatid
exchange frequency.
The effectiveness of green tea in treating any type of
diarrhea and typhoid has been known in Asia since
ancient times [41-43]. Green tea catechins have an inhi-
bitory effect on Helicobacter pylori infection [44,45].
Effects of green tea against the influenza virus, especially
in its earliest stage, as well as against the Herpes simplex
virus have also been demonstrated [46-48]. Furthermore,
Weber et al. [9] observed that adenovirus infection is
inhibited in vitro by green tea catechins.
In humans, Hirasawa and Takada [49] studied the
antifungal activity of green tea catechins against Can-
dida albicans and the convenience of a combined treat-
ment with catechins and lower doses of antimycotics,
which may help to avoid the side effects of antimycotics.
Green tea consumption has also been associated with
increased bone mineral density, and it has been identi-
fied as an independent factor protecting against the risk
of hip fractures; this effect was considered independent
of smoking status, hormone replacement therapy, coffee
drinking, and the addition of milk to tea [50]. Park et al.
[51] observed the positive effects of green tea extracts
and GTPs on the proliferation and activity of bone cells.
The proliferation of hepatic stellate cells is closely
related to the progression of liver fibrosis in chronic
liver diseases, and EGCG has a potential inhibitory effect
on the proliferation of these cells [52,53]. Green tea
strengthens the immune system action because it pro-
tects it against oxidants and radicals. Recent studies sug-
gested that GTPs might protect against Parkinson’sa n d
Alzheimer’s diseases and other neurodegenerative dis-
eases [10,54]. Studies have demonstrated GTP neuropro-
tectant activity in cell cultures and animal models, such
as the prevention of neurotoxin-induced cell injury [54].
Green tea is considered to be useful for insect stings
due mainly to its anti-inflammatory effects and its capa-
city to stop bleeding [55,56]. Some studies have sug-
gested an inverse association between green tea
consumption and the risk of kidney stone formation
[41,57]. In an experimental cataractogenesis system,
green tea acted by preserving the antioxidant defense
system of the lens [58]. Skrzydlewska et al. [59] indi-
cated a beneficial effect of green tea in alcohol intoxica-
tion. In addition to all of these reported properties,
which have helped the recognition of green tea as func-
tional food by some authors [60], green tea is also cur-
rently used in the preparation of a variety of foods,
pharmaceutical preparations, dentifrices, and cosmetics
[61].
Tea has been shown anticarcinogenic effects against
breast cancer in experimental studies [62]. However,
epidemiologic evidence that tea protects against breast
cancer has been inconsistent [62]. A case-control study
was conducted in southeastern China between 2004 and
2005 [63]. The incidence cases were 1009 female
patients aged 20-87 years with histologically confirmed
breast cancer, and the 1009 age-matched controls were
healthy women randomly recruited from breast disease
clinics. Information on duration, frequency, quantity,
preparation, and type of tea consumption as well as diet
and lifestyle were collected by face-to-face interviews
using a validated and reliable questionnaire. In compari-
son with non-tea drinkers, green tea drinkers tended to
reside in urban settings, to have more education, and to
consume more coffee, alcohol, soy, vegetables, and
fruits. After adjusting established and potential con-
founding factors, green tea consumption was associated
with a reduced risk of breast cancer. Similar dose-
response relationships were observed for duration of
drinking green tea, number of cups consumed, and new
batches prepared per day.
Hsu et al. [64] demonstrated the effects of supplemen-
tation with decaffeinated green tea extract (catechins) on
hemodialysis-induced reactive oxygen species, athero-
sclerotic disease risk factors, and proinflammatory cyto-
kines. The pharmacokinetics of one oral dose of
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hemodialysis patients. The authors compared the antioxi-
dant effects of three different doses (0, 455, and 910 mg)
of oral catechins with that of oral vitamin C (500 mg)
during a hemodialysis session. In patients, catechin
supplementation reduced hemodialysis-enhanced plasma
hypochlorous acid activity more effectively than did
placebo or vitamin C. Between the treatments with 455
and 910 mg catechins, no significant difference was
found in the reduction of plasma hypochlorous acid
activity. Catechins also significantly reduced proinflam-
matory cytokine expression enhanced by hemodialysis.
Effects on absorption of metal ions
Tea catechins can affect iron absorption, particularly in
groups at risk of iron deficiency [65,66], but their effects
on other ions are poorly understood. Green tea inges-
tion over a long period does not affect the apparent
absorption of copper, whereas it decreases that of zinc
and increases that of manganese [67]. However, catechin
intake does not affect the plasma concentration of these
ions [68]. Green tea catechins have the potential to
affect absorption and metabolism of ions because flavo-
noids interact with a variety of metal ions [69].
Effects on drug-metabolizing enzymes
Long-term ingestion of green tea increases UDP-glucur-
onosyl transferase activity in rats [66,70,71], and after
being absorbed, catechins are metabolized by drug-
metabolizing enzymes in various organs [72,73]. Thus,
the increased glucuronidation through UDP-glucurono-
syl transferase induction is postulated to contribute to
the anticarcinogenic effect of green tea by facilitating
the metabolism of chemical carcinogens into inactive
products that are readily excreted. The interaction
between 2-amino-3-methylimidazol (4,5-f)quinoline (IQ)
and green tea catechin metabolism was examined [74].
IQ is a precarcinogen that was originally detected in an
extract of fried meat. The major route of IQ biotransfor-
mation in rats is cytochrome P450 in the first step, fol-
lowed by conjugation to a sulfate and a glucuronide
conjugate. Green tea modifies IQ metabolism in rats,
increasing the formation of IQ glucuronides, which are
then excreted in the urine. Moreover, protection against
cancers induced by polycyclic aromatic hydrocarbons by
green tea catechins may be due to the inhibition of their
cytochrome P450 metabolism, but the effect of green
tea on cytochrome P450 enzymes depends on the parti-
cular form. The long-term consumption of green tea
increases cytochrome P450 1A1 and 1A2 activities, but
not 2B1 and 2E1 activities, in normal rats. However, it
is difficult to draw conclusions about a beneficial effect
of green tea against carcinogens involving only modula-
tion of this metabolic pathway.
Effects on antioxidant markers and oxidative stress
Green tea is a popular neutraceutical as an antioxidant.
Antioxidants are compounds that protect cells against
the damaging effects of reactive oxygen species, such as
singlet oxygen, superoxide, peroxyl radicals, hydroxyl
radicals, and peroxynitrite. An imbalance between anti-
oxidants and reactive oxygen species results in oxidative
stress, leading to cellular damage [75]. Catechins are
hypothesized to help protect against these diseases by
contributing, along with antioxidant vitamins (i.e., vita-
mins C and E) and enzymes (i.e., superoxide dismutase
and catalase), to the total antioxidant defense system
[76].
In vivo studies showed that green tea catechins
increase total plasma antioxidant activity [77,78]. Intake
of green tea extracts also increases the activity of super-
oxide dismutase in serum and the expression of catalase
in the aorta; these enzymes are implicated in cellular
protection against reactive oxygen species [78,79]. This
action is combined with direct action on oxygen species
by a decrease in the nitric oxide plasma concentration
[80]. Malondialdehyde, a marker of oxidative stress, also
decreases after green tea intake [77,80]. These results
suggest that catechins could have a direct (antioxidant)
or indirect (increase of activity or expression) effect.
Since catechins can act as antioxidants in vitro,t h e y
might prevent the oxidation of other antioxidants, such
as vitamin E. However, ingestion of green tea catechins
does not modify the plasma status of vitamins E and C
in vivo [78,81,82]. Nevertheless, one study reported that
catechins increase vitamin E concentration in low-den-
sity lipoprotein [81] and in this way could protect low-
density lipoprotein against peroxidation [77].
Pilipenko et al. [83] assessed the tolerance of tableted
green tea and its effect on the antioxidant status indices.
Twenty-five patients with different gastrointestinal
pathologies were included in the study and divided into
treatment and control groups. The tolerance of tableted
green tea was good in the treatment group, who showed
better dynamics of quality-of-life indices, especially in
scales of body pain and social functioning. There were
no significant differences in biochemical analysis
between the groups, which may indicate the safety of
this product. Analysis revealed that the treatment group
showed a decreased level of all antioxidant status
indices, as reflected in a significant decreasing of the
lipid peroxidation index from 4.63 to 4.14.
Effects on carbohydrate metabolism
Type II diabetes is a heterogeneous disorder that
involves resistance of glucose and lipid metabolism in
peripheral tissues to the biological activity of insulin and
inadequate insulin secretion by pancreatic b cells [84].
Animal models of diabetes are available: Zucker rats,
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or alloxan, which destroys pancreatic b cells; and treat-
ment with sucrose-rich diets, which induces obesity and
insulin resistance.
In a study by Sabu et al. [85], administration of GTPs
(500 mg/kg) to normal rats increased glucose tolerance
significantly at 60 minutes. GTPs were also found to
reduce significantly serum glucose levels in alloxan dia-
betic rats at a dose of 100 mg/kg. Continued daily
administration (15 days) of the extract at 50 or 100 mg/
kg produced 29% and 44% reduction, respectively, in the
elevated serum glucose level produced by alloxan
administration. Elevated hepatic and renal enzymes pro-
duced by alloxan were found to be reduced significantly
by GTPs. The serum lipid peroxidation level was
increased by alloxan and reduced significantly by the
administration of 100 mg/kg of GTPs. Decreased liver
glycogen resulting from alloxan administration showed a
significant increase after GTP treatment. The GTP-trea-
ted group showed increased antioxidant potential, as
seen from improvements in superoxide dismutase and
glutathione levels. However, catalase, lipid peroxidation,
and glutathione peroxidase levels were unchanged.
These results indicate that alterations in the glucose uti-
lizing system and oxidation status in rats that were
increased by alloxan were partially reversed by the
administration of GTPs [85].
Catechins also reduced plasma triglyceride levels in an
oral glucose-tolerance test in normal rats [86]. Green tea
extract intake reduced these values in both Zucker rats
and rats fed a sucrose-rich diet [87,88]. Several human-
and animal-based studies suggested that green tea and its
flavonoids have antidiabetic effects [86,89,90]. Green tea
flavonoids were also shown to have insulin-like activities
[91] as well as insulin-enhancing activity [92].
The antihyperglycemic effect of black tea was reported
by Gomes et al. [93]. EGCG was found to inhibit intest-
inal glucose uptake by the sodium-dependent glucose
transporter SGLT1, indicating its increase in controlling
blood sugar [94]. Streptozotocin diabetic rats showed
increased sensitivity to platelet aggregation and throm-
bosis, and this abnormality could be improved by dietary
catechins from green tea [95,96]. Alloxan produces oxy-
gen radicals in the body, which cause pancreatic injury
[75] and are responsible for increased blood sugar.
Under in vivo conditions, glutathione acts as an anti-
oxidant, and its decrease was reported in a diabetes mel-
litus model [97]. The increased glutathione content in
t h el i v e ro ft h er a t st r e a t e dw i t hG T P sm a yb eo n eo f
the factors responsible for the inhibition of lipid peroxi-
dation. Superoxide dismutase and catalase are the two
major scavenging enzymes that remove the toxic free
radicals in vivo. Vucic et al. [98] reported that the activ-
ity of superoxide dismutase is low in diabetes mellitus.
The Mediterranean Islands (MEDIS) epidemiological
study is a cross-sectional health and nutrition survey that
aims to evaluate the association between various sociode-
mographic, bioclinical, dietary, and other lifestyle habits
and the prevalence of the common cardiovascular disease
risk factors (i.e., hypertension, dyslipidemia, diabetes, and
obesity) among elderly people without a history of any
chronic disease and living in the Mediterranean islands.
Because data relating tea consumption with clinical char-
acteristics are lacking in elderly populations, in the context
of the MEDIS study, the authors sought to evaluate
whether green tea consumption is independently asso-
ciated with fasting blood glucose levels and the prevalence
of type II diabetes mellitus [99]. An earlier study was
aimed at providing evidence of improvement in glucose
metabolism in diabetic mice and healthy humans upon
green tea consumption [35]. Green tea promoted glucose
metabolism in healthy human volunteers at 1.5 g/kg as
shown in oral glucose-tolerance tests. Green tea also low-
ered blood glucose levels in diabetic db+/db+ mice and
streptozotocin-diabetic mice two to six hours after admin-
istration at 300 mg/kg without affecting serum insulin
level, whereas no effect was observed in control mice
(+m/+m and normal ddY mice).
Effect of EGCG on diabetes
A study by Waltner-Law et al. [91] provided compelling
in vitro evidence that EGCG decreases glucose produc-
tion of H4IIE rat hepatoma cells. The investigators
showed that EGCG mimics insulin, increases tyrosine
phosphorylation of the insulin receptor and the insulin
receptor substrate, and reduces gene expression of the
gluconeogenic enzyme phosphoenolpyruvate carboxyki-
nase. Recently, green tea and green tea extracts were
demonstrated to modify glucose metabolism beneficially
in experimental models of type II diabetes mellitus
[35,100]. In addition, EGCG ameliorates cytokine-
induced b cell damage in vitro [101] and prevents the
decrease of islet mass induced by treatment with multi-
ple low doses of streptozotocin in vivo [102].
Lambert et al. [103] showed that intragastric adminis-
tration of EGCG at a dose of 75 mg/kg resulted in a
Cmax of 128 mg/l total plasma EGCG and a terminal
half-life of 83 minutes. Furthermore, in humans an oral
intake of EGCG at a dose of 50 mg (0.7 mg/kg) resulted
in a Cmax of 130 mg/l total plasma EGCG and a term-
inal half-life of 112 minutes [104]. These results indicate
that rodents must be orally administered 100- to 600-
fold more EGCG (depending on whether they are admi-
nistered by gavage or by feed admixture) to achieve
similar plasma concentrations as those found in
humans. Total plasma EGCG concentrations shown to
be efficacious in mice and rats can be reached by an
intake of low to moderate doses of EGCG in humans.
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The effects of tea on obesity and diabetes have received
increasing attention. Tea catechins, especially EGCG,
appear to have antiobesity and antidiabetic effects [105].
African black tea extract has been shown to suppress
the elevation of blood glucose during food intake and
reduce the body weight in KK-A(y)/TaJcl diabetic mice
[106]. Although few epidemiological and clinical studies
have shown the health benefits of EGCG on obesity and
diabetes, the mechanisms of its actions are emerging
based on various laboratory data. These mechanisms
may be related to certain pathways, such as through the
modulations of energy balance, endocrine systems, food
intake, lipid and carbohydrate metabolism, and redox
status [88].
A double-blind, placebo-controlled, cross-over design
study showed that consumption of a beverage contain-
ing green tea catechins, caffeine, and calcium increases
24-h energy expenditure by 4.6%, but the contribution
of the individual ingredients could not be distinguished.
It was suggested that such modifications were sufficient
to prevent weight gain. It has been reported that the
b o d yw e i g h t so fr a t sa n dt h e i r plasma triglyceride, cho-
lesterol, and low-density lipoprotein cholesterol were
significantly reduced by feedings of Oolong, black, and
green tea leaves to the animals. In addition, the inhibi-
tion of growth and suppression of lipogenesis in MCF-7
breast cancer cells may be through down-regulation of
fatty acid synthase gene expression in the nucleus and
stimulation of cell energy expenditure in the mitochon-
dria [107,108]. When fed to mice, EGCG purified from
green tea decreased diet-induced obesity in mice by
decreasing energy absorption and increasing fat oxida-
tion [109]. The increased and prolonged sympathetic sti-
mulation of thermogenesis by the interaction between
polyphenols and caffeine could be of value in assisting
the management of obesity [110].
Recent data from human studies indicate that the con-
sumption of green tea and green tea extracts may help
reduce body weight, mainly body fat, by increasing post-
prandial thermogenesis and fat oxidation. In a rando-
mized, double-blind, placebo-controlled, cross-over pilot
study, six overweight men were given 300 mg EGCG
per day for two days. Fasting and postprandial changes
in energy expenditure and substrate oxidation were
assessed. Resting energy expenditure did not differ sig-
nificantly between EGCG and placebo treatments,
although during the first postprandial monitoring phase,
respiratory quotient values were significantly lower with
EGCG treatment compared to the placebo. These find-
ings suggest that EGCG alone has the potential to
increase fat oxidation in men and may thereby contri-
bute to the antiobesity effects of green tea. However,
more studies with a greater sample size and a broader
range of age and body mass index are needed to define
the optimal dose [111].
Adverse effects of green tea
Although green tea has several beneficial effects on
health, the effects of green tea and its constituents may
be beneficial up to a certain dose yet higher doses may
cause some unknown adverse effects. Moreover, the
effects of green tea catechins may not be similar in all
individuals. EGCG of green tea extract is cytotoxic, and
higher consumption of green tea can exert acute cyto-
toxicity in liver cells, a major metabolic organ in the
body [112]. Another study found that higher intake of
green tea might cause oxidative DNA damage of ham-
ster pancreas and liver [113]. Yun et al. [114] clarified
that EGCG acts as a pro-oxidant, rather than an antioxi-
dant, in pancreatic b cells in vivo. Therefore, high intake
of green tea may be detrimental for diabetic animals to
control hyperglycemia. At a high dose (5% of diet for 13
wk), green tea extract induced a thyroid enlargement
(goiter) in normal rats [115,116]. This high-level treat-
ment modified the plasma concentrations of the thyroid
hormones. However, drinking even a very high dietary
amount of green tea would be unlikely to cause these
adverse effects in humans.
Harmful effects of tea overconsumption (black or
green) are due to three main factors: (1) its caffeine con-
tent, (2) the presence of aluminum, and (3) the effects of
tea polyphenols on iron bioavailability. Green tea should
not be taken by patients suffering from heart conditions
or major cardiovascular problems. Pregnant and breast-
feeding women should drink no more than one or two
cups per day, because caffeine can cause an increase in
heart rhythm. It is also important to control the conco-
mitant consumption of green tea and some drugs, due
to caffeine’s diuretic effects [117]. Some studies revealed
the capacity of tea plants to accumulate high levels of
a l u m i n u m .T h i sa s p e c ti si m p o r t a n tf o rp a t i e n t sw i t h
renal failure because aluminum can be accumulated by
the body, resulting in neurological diseases; it is there-
fore necessary to control the intake of food with high
amounts of this metal [118]. Likewise, green tea cate-
chins may have an affinity for iron, and green tea infu-
sions can cause a significant decrease of the iron
bioavailability from the diet [119].
Conclusions
Laboratory studies showed the health effects of green
tea. As the human clinical evidence is still limited,
future research needs to define the actual magnitude
of health benefits, establishes the safe range of tea con-
sumption associated with these benefits, and elucidates
the mechanisms of action. Development of more speci-
fic and sensitive methods with more representative
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biomarkers will give a better understanding of how
green tea interacts with endogenous systems and other
exogenous factors. Definitive conclusions concerning
the protective effect of green tea have to come from
well-designed observational epidemiological studies
and intervention trials. The development of biomarkers
for green tea consumption, as well as molecular mar-
kers for its biological effects, will facilitate future
research in this area.
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